Munch-a-Biotech Today Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Munch-a-Biotech Today

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote ()	2/7/1999 6:03:00 PM
From: Dave K	Read Replies (1) of 3158

Helpful and Interesting Munch-On thread. Here's a small related contribution. Lots more munch related stories showing up all over. cbs.marketwatch.com Clip... The catalyst that will spark recognition of the true value of small biotechnology companies, both in the U.S. and the U.K., is unclear but there are several possibilities. First, that approvals and sales of products could increase to significantly over the next few years that the sector as a whole is re-rated. Second, that the demands of big pharma for late-stage products to fuel their growth rates could incite a buying spree of later stage small biotechs, just for their product values. Finally, M&A activity could consolidate the sector into fewer, larger, and more "investible" companies. The dream scenario is that all three happen, and we think to an extent all three will.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next